Brand check
Is Calpol banned in India?
Last checked 1 October 2026
Calpol is not banned in India as of 1 Oct 2026; it is single-ingredient paracetamol, which no Section 26A notification covers.
- Classification
- No ban or recall found in official records
- Decided by
- CDSCO / Ministry of Health and Family Welfare
- Reference
- No Section 26A notification for paracetamol
- Evidence
- Government document
- Latest action
- 4 October 2025
- Last checked
- 1 October 2026
Calpol Six Plus advertisement (Wellcome Collection). Photo: Calpol Six Plus Wellcome L0068137.jpg by Unknown author (CC BY 4.0). Brand names and logos belong to their owners and are used here to identify the product this entry is about. All photo credits.
CDSCO: Drugs banned in India (consumer section)
Scope. A record here does not by itself mean a product or company is unsafe or banned today. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Below: Blacklisted's explanationWe organise and explain what the document says. The document above is the authority.
Key facts
- Governing authority
- CDSCO, Ministry of Health and Family Welfare
- Ban notification
- None
- Marketer
- GSK / Haleon (India)
- Paediatric syrup
- Not covered by the Oct 2025 DGHS advisory, which concerns cough syrups
- NSQ history
- Check individual batches against CDSCO monthly alerts
Where the claim comes from
Calpol is the paracetamol brand most associated with children, so the October 2025 advisory against cough syrups for under-2s and the 2025 to 2026 restrictions on chlorpheniramine + phenylephrine drops for under-4s produced 'is Calpol banned' searches. Neither action concerns paracetamol. The 2022 Dolo tax story and the 2024 FDC list added to it.
Calpol is a paracetamol brand sold as tablets and as a paediatric syrup. It is not banned in India, and no regulator has proposed banning it.
The government's recent actions on children's medicines are the reason for the question. On 4 October 2025 the Directorate General of Health Services advised that cough syrups should not be prescribed or dispensed to children below two years, after the deaths linked to diethylene-glycol-contaminated syrups. In April 2025 and again in August 2026 the Health Ministry required chlorpheniramine + phenylephrine products to carry a "not for children below four years" label. Both measures concern cough and cold products. Paracetamol syrup is a fever and pain medicine and is outside both.
Single-ingredient paracetamol has never been the subject of a Section 26A notification. The various FDC bans since 2016 removed combinations in which paracetamol is mixed with decongestants, antihistamines, muscle relaxants or opioids; they did not touch paracetamol alone.
What parents should still do is ordinary: dose by weight as advised, keep to the interval on the label, and check the batch number if a CDSCO alert names a paracetamol product. Batch-level findings, when they occur, are about one production lot, not the brand.
What this means for you
Safe to continue as directed
Calpol syrup and tablets are licensed; dose by weight for children as your doctor advised.
It is not a cough syrup
The 2025 advisory and the 2025 to 2026 label rules for children concern cough and cold combinations, not paracetamol.
This is a record of official orders, not medical advice. Do not stop a prescribed medicine without asking your doctor or pharmacist.
Batches flagged in CDSCO alerts
Products whose name matches this brand or molecule in CDSCO monthly NSQ alerts. A flagged batch is a single batch; the company's response, where reported, is noted on the page above.
| Product | Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|---|
| Paracetamol, Phenylephrine Hydrochloride, Chlorpheniramine Maleate and Caffeine Tablets | Batch DRT25284Mfg Sep 2025 · Exp Aug 2027 | Eastern HealthcareUttarakhand | DescriptionDescription | RDTL, Bellary, KarnatakaState lab | Sep 2026 |
| Paracetamol, Phenylephrine Hydrochloride, Caffeine & Diphenhydramine Hydrochloride Tablets | Batch DHPLT/030725Mfg Jul 2025 · Exp Jun 2027 | Durgaji Healthcare Pvt.LtdUttarakhand | The sample does not conform to claim as per Schedule V, Drugs & Cosmetics Acts and rules 1945 with respect to test for 'Disintegration Time' and is also not of standard quality for the reason stated under 'Description'.Description | CDL, KolkataCDSCO lab | Sep 2026 |
| Paracetamol, Phenylephrine HCL, Chlorpheniramine Maleate, Sodium Citrate & Menthol Suspension | Batch SKL260238Mfg Mar 2026 · Exp Feb 2028 | S Kins PharmaHimachal Pradesh | The sample does not coform to the claim to the prescribed standard for Patent & Proprietary medicine with respect to the assay of menthol.Assay | Drug Testing Laboratory, Baddi, Solan, H.PState lab | Sep 2026 |
| Paracetamol Tablets IP 650 mg, | Batch CAAL25019Mfg Apr 2025 · Exp Mar 2028 | Curetech Formulations Pvt. LtdHimachal Pradesh | Sample does not conform to IP standards. It fails the test Dissolution.Dissolution | RDTL , ErnakulamState lab | Sep 2026 |
| Paracetamol Tablets IP 650 mg | Batch TV6122Mfg Aug 2026 · Exp Jul 2028 | Alpa Laboratories LtdMadhya Pradesh | The sample does not conform to IP with respect to the DissolutionDissolution | SDTL, GuwahatiState lab | Sep 2026 |
| Paracetamol Tablets IP 650 mg | Batch IPCL25017Mfg Mar 2025 · Exp Feb 2028 | Pinnacle Life Science Pvt LtdHimachal Pradesh | Test for DissolutionDissolution | RDTL, Bellary, KarnatakaState lab | Sep 2026 |
| Paracetamol Tablets IP 500mg | Batch PCTJ26007Mfg Mar 2026 · Exp Feb 2028 | Vivek Pharmaceuticals Pvt. LtdJammu & Kashmir | The sample does not conform to IP with respect to the DissolutionDissolution | SDTL, GuwahatiState lab | Sep 2026 |
| Paracetamol Tablets IP 500 mg | Batch PAK-815Mfg Nov 2024 · Exp Oct 2027 | Healer's Lab Unit IIHimachal Pradesh | The Sample does not conform to IP standards with respect to the test Dissolution.Dissolution | DTL, ThrissurState lab | Sep 2026 |
| Paracetamol Sustained Release Tablets USP | Batch BRD240848AMfg Dec 2024 · Exp Nov 2027 | BRD Medilabs (Unit-II)Himachal Pradesh | Sample does not conform to USP Standards. It fails the test Dissolution as per USP.Dissolution | RDTL , ErnakulamState lab | Sep 2026 |
| Paracetamol Phenylepherine Hydrochloride Caffine (Anhydrous) Diphenhydramine Hydrochloride | Batch T-2511129Mfg Nov 2025 · Exp Oct 2027 | Aagya Biotech Pvt. Ltd. 1.5 kmUttarakhand | DescriptionDescription | SDT&RL, BhubanesearState lab | Sep 2026 |
| Paracetamol Paediatric Oral Suspension IP | Batch PAMLA002Mfg Aug 2025 · Exp Jul 2027 | Laborate Pharmaceuticals India LtdHimachal Pradesh | The sample does not conform to IP in respect of content of Paracetamol.Other | LUCKNOW, Uttar PradeshState lab | Sep 2026 |
| Paracetamol IP 500 mg Tablets | Batch APRCT-2501Mfg May 2025 · Exp Apr 2027 | Konis Pharmaceuticals Pvt. LtdHimachal Pradesh | Sample Does not meets the Specifications wrt, Assay and Dissolution Test as per IP.Assay | State Lab, DCL, TelanganaState lab | Sep 2026 |
| PARACETAMOL PAEDIATRIC ORAL SUSPENSION | Batch PAD1130Mfg Feb 2026 · Exp Jan 2028 | REVIVE Formulations India Pvt. LtdTamil Nadu | Misbranded-Incorrect LabellingMisbranded | DTL, PuducherryState lab | Sep 2026 |
| PARACETAMOL AND TRAMADOL TABLETS IP | Batch DT644Mfg Jul 2025 · Exp Jun 2027 | Prim Drugs & Pharmaceuticals (I) Pvt. LtdTamil Nadu | Failed Disintegration and DissolutionDissolution | DTL, PuducherryState lab | Sep 2026 |
| Meloxicam, Paracetamol And Serratiopeptidase Bolus (Vet) | Batch PT25367Mfg Dec 2025 · Exp May 2028 | Prispag PharmaPunjab | Uneven Light Brown Coloured Spots are observed on the Surface of Almost all the Bolus.Description | FDAL, M. S Chhatrapatri Sambhajinagar, F.D.A Mahrasthra StateState lab | Sep 2026 |
| Meloxicam and Paracetamol Bolus (Vet) | Batch Nov-21Mfg Apr 2026 · Exp Mar 2028 | Unitech Pharmaceuticals (India) | DescriptionDescription | RDTL, Bellary, KarnatakaState lab | Sep 2026 |
| Mefenamic Acid and Paracetamol Tablets | Batch T3209Mfg May 2024 · Exp Apr 2027 | Jersy Pharma | Assay for Mefenamic AcidAssay | DTL, Bengaluru, KarnatakaState lab | Sep 2026 |
| Ibuprofen &Paracetamol Tablets IP | Batch KFM-2501Mfg Mar 2025 · Exp Feb 2028 | Askon Health Care | The sample does not conform to standard quality in respect of the test for ?Dissolution? and Description performed.Dissolution | SDTL, Agartala, TripuraState lab | Sep 2026 |
| Ibuprofen & Paracetamol Tablets | Batch OT-13158Mfg Jun 2026 · Exp May 2028 | Omnison Pharma (P) Ltd. G-456 & 457 | The sample does not conform to standard, in respect of Uniformity of Dispersion.Uniformity of weight/content | LUCKNOW, Uttar PradeshState lab | Sep 2026 |
| Flupirtine Maleate and Paracetamol Tablets | Batch T26H291Mfg Aug 2026 · Exp Jul 2028 | Dr. ARS (India) Labs Pvt Ltd | Content of Flupirtine MaleateOther | Drugs Testing Laboratory,Madurai-19State lab | Sep 2026 |
Ingredient records: Paracetamol
Sources
Government documents
- Regulator
News reports
- AIR: Health ministry advises cough syrups should not be prescribed or dispensed to children below two yearsNewsAll India Radio · 4 October 2025
- Medical Dialogues: Health ministry restricts chlorpheniramine + phenylephrine FDCs for children below 4, mandates warning labelsNewsMedical Dialogues